A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

NCT02781311 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia

Interventions

DRUG: Setipiprant
DRUG: Placebo
DRUG: Finasteride

Sponsor

Allergan